TEDA BIOMEDICAL (08189): Xia Ruizhe has been reassigned as a non-executive director.
Taeda Biology (08189) announced that Mr. Xia Ruizhe, an executive director of the company, has applied to be reassigned as a non-executive director due to regulatory restrictions related to his Hong Kong Securities and Futures Commission Type 9 Asset Management RO license.
TEDA BIOMEDICAL (08189) announced that Mr. Xia Ruizhe, an executive director of the company, has applied to be reappointed as a non-executive director due to regulatory restrictions related to his RO license held by the Securities and Futures Commission of Hong Kong.
Related Articles

VANOV HOLDINGS (02260): Jiang Zhaozhe appointed as independent non-executive director.

LIANLIAN (02598) spent 1.5245 million Hong Kong dollars to repurchase 267,000 shares on April 30.

Merck & Co., Inc. (MRK.US) narrows full-year guidance, strong demand for new drugs drives Q1 revenue beyond expectations.
VANOV HOLDINGS (02260): Jiang Zhaozhe appointed as independent non-executive director.

LIANLIAN (02598) spent 1.5245 million Hong Kong dollars to repurchase 267,000 shares on April 30.

Merck & Co., Inc. (MRK.US) narrows full-year guidance, strong demand for new drugs drives Q1 revenue beyond expectations.

RECOMMEND





